In patients with RCC, exceptional response to immunotherapy may be related to clonal neoantigen-driven cytotoxic T-cell ...

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous ...

LeukemiaANT308 has shown strong single-agent anti-leukemia activity in 2 mouse models.   (2) Pancreatic cancerANT308 has shown synergistic effects with anti-PD-1 checkpoint inhibitors in 3 pancreatic ...

Southwest United Graduate School, Yunnan Key Laboratory of Cell Metabolism and Diseases, State Key Laboratory of Conservation and Utilization of Bio-resources in Yunnan Center for Life Sciences, ...

Explore the role of the extracellular matrix (ECM) in prostate cancer progression and discover natural therapies, including ...

What was of particular interest (in relation to the recovery of John Famechon) was the process of discovering what was ...

Turmeric (Curcuma longa), a vibrant yellow spice, a rhizomatous herbaceous plant from the ginger family (Zingiberaceae), has ...

Recent years have witnessed notable progress in tailoring treatments for solid tumors using biomarkers. Nevertheless, identifying specific biomarkers for ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced its 2025 priorities and upcoming ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...